From Yahoo Finance: 2025-06-29 12:53:00

Elevance Health, Inc. (NYSE:ELV) is considered one of the best fundamental stocks to buy according to hedge funds. UBS reaffirmed its Buy rating and $555 price target for ELV, despite the company adjusting its 2025 earnings distribution. Originally predicting first-half earnings to account for 62-63% of full-year results, the company now expects them to account for 60%.

Three main factors impacted Elevance Health, Inc.’s (NYSE:ELV) second-quarter earnings expectations: higher clarity in ACA populations, out-of-network billing challenges in behavioral health services, and Medicaid cost trends. The company is working to reduce expenses to improve performance in the second half of the year.

Formerly known as Anthem, Inc., Elevance Health, Inc. (NYSE:ELV) is a prominent health benefits provider in the U.S., offering various insurance services. While ELV shows investment potential, there are AI stocks with greater upside potential and lower risk. Investors can explore undervalued AI stocks in a free report.

For more insights on top stocks for 2025 and retirement, visit the provided links. No disclosures were made in the article.



Read more at Yahoo Finance: UBS Reaffirms Buy on Elevance Despite Adjusted 2025 Earnings Outlook